Foulkes Helena

Average Profitability
2.32%
Insider Buys Quantity
1
Insider Buys Sum
$49,910.98
Insider Sells Quantity
14
Insider Sells Sum
$24.48M

Insider Activity of Foulkes Helena

The largest purchase of all time was on 2013-11-21 and amounted to 626 shares of The Home Depot, Inc. for $49,911.

The largest sale of all time was on 2017-09-15 and amounted to 78680 shares of CVS Health Corporation for $5.37M.

Biography of Foulkes Helena

No biography is available at this moment.

2018-02-16SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
39,930
0.0032%
$58.05$2.32M-4.96%
2017-09-15SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
78,680
0.0064%
$68.20$5.37M-14.8%
2017-06-26SaleCVS Health Corporation
CVS
EVP, President-CVS Pharmacy
40,666
0.004%
$80.00$3.25M-8.37%
2017-06-19SaleCVS Health Corporation
CVS
EVP, President-CVS Pharmacy
40,664
0.0039%
$76.98$3.13M-5.56%
2014-11-07SaleCVS Health Corporation
CVS
EVP, President-CVS/pharmacy
32,022
0.002%
$61.26$1.96M+16.06%
2013-11-21PurchaseThe Home Depot, Inc.
HD
director
626
<0.0001%
$79.73$49,911+2.32%
2013-11-14SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
24,114
0.0011%
$34.96$843,025+17.22%
2013-09-13SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
40,734
0.0033%
$60.00$2.44M+23.13%
2013-09-12SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
12,812
0.0006%
$36.23$464,179+23.94%
2013-09-09SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
47,568
0.0027%
$41.17$1.96M+25.27%
2012-06-21SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
29,187
0.0018%
$36.71$1.07M+8.03%
2012-03-01SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
5,588
0.0004%
$44.89$250,845+2.51%
2011-06-16SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
26,953
0.0015%
$28.19$759,796+4.89%
2010-03-17SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
7,000
0.0005%
$34.93$244,510-7.35%
2010-02-18SaleCVS Health Corporation
CVS
EVP & President-CVS Pharmacy
12,280
0.0009%
$34.00$417,520-4.05%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.